本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Bone Biologics Corp

0.5508
-0.0102-1.82%
盤後0.57410.0233+4.23%19:49 EDT
成交量:1.85萬
成交額:1.02萬
市值:151.81萬
市盈率:-0.34
高:0.5650
開:0.5608
低:0.5500
收:0.5610
52周最高:2.89
52周最低:0.5402
股本:275.61萬
流通股本:275.54萬
量比:0.57
換手率:0.67%
股息:- -
股息率:- -
每股收益(TTM):-1.6080
每股收益(LYR):-2.6500
淨資產收益率:-54.96%
總資產收益率:-33.46%
市淨率:0.39
市盈率(LYR):-0.21

資料載入中...

2024/03/02

SEC問詢函

Form CORRESP - Correspondence
2024/03/01

重要事件披露

Form 8-K - Current report
2024/03/01

SEC問詢函

Form CORRESP - Correspondence
2024/02/29

SEC問詢函

Form CORRESP - Correspondence
2024/02/28

SEC問詢函

Form CORRESP - Correspondence
2024/02/26

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/23

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/21

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/01/23

SEC問詢函

Form CORRESP - Correspondence
2024/01/13

重要事件披露

Form 8-K - Current report
2024/01/11

重要事件披露

Form 8-K - Current report
2024/01/10

重要事件披露

Form 8-K - Current report
2024/01/03

重要事件披露

Form 8-K - Current report
2023/12/21

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/18

重要事件披露

Form 8-K - Current report
2023/12/13

重要事件披露

Form 8-K - Current report